Brief: FDA Updates Recommendations For Use Of Renuvion/J-Plasma Device For Certain Aesthetic Procedures
June 2 (Reuters) - FDA:
* FDA UPDATES RECOMMENDATIONS FOR USE OF RENUVION/J-PLASMA
DEVICE
FOR CERTAIN AESTHETIC PROCEDURES
* FDA - USE OF RENUVION DERMAL HANDPIECE HAS NOT BEEN
DETERMINED
TO BE SAFE OR EFFECTIVE FOR ALL DERMAL RESURFACING PROCEDURES
* FDA - LABELING AND TRAINING FOR NEW HANDPIECE INCLUDE
INSTRUCTIONS FOR DEVICE POWER SETTINGS AND NUMBER OF TREATMENT
PASSES
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Apyx Medical
See all newsBrief: Apyx Medical - Appoints Stavros Vizirgianakis As Executive Chairman Effective June 11, 2026
Brief: Apyx Medical Corporation Receives Expanded FDA 510(K) Clearance Adding Power Liposuction Capability To AYON Body Contouring System™
Apyx Medical Q1 revenue beats estimates, outlook raised
Preview: Weight-loss revolution sparks new appetite for aesthetics firms
Apyx Medical Q4 revenue beats on Surgical Aesthetics unit strength